Targeted chemo for rare brain tumors shows early promise but study halted
NCT ID NCT04994977
First seen Mar 30, 2026 · Last updated May 14, 2026 · Updated 10 times
Summary
This early-stage study tested giving chemotherapy directly into the brain's arteries to shrink rare, aggressive choroid plexus tumors before a second surgery. Only one person enrolled before the study was stopped early. The goal was to see if this approach is safe and can make tumors smaller, but results are very limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOROID PLEXUS CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Weill Cornell Medicine
New York, New York, 10025, United States
Conditions
Explore the condition pages connected to this study.